The long-term outcome of tacrolimus in cadaveric kidney transplantation from non-heart beating donors

Clinical Transplantation

Volumn 19, Issue 2, 2005, Pages 153-157

  Fukuhara, Nobuyuki ^a,f   Ono, Yoshinari ^a   Hattori, Ryohei ^a   Nishiyama, Naoki ^b   Yamada, Shin ^c   Kamihara, Osamu ^d   Kinukawa, Tsuneo ^e   Ohshima, Shinichi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Nagoya Memorial Hospital   (Japan)

^c Okazaki City Hospital   (Japan)

^d Komaki Shimin Hospital   (Japan)

^e CHUKYO HOSPITAL   (Japan)

^f Handa City Hospital   (Japan)

Author keywords

Cadaveric kidney transplantation; Non heart beating donor; Tacrolimus

Indexed keywords

15 DEOXYSPERGUALIN; CYCLOSPORIN; LIPID; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MIZORIBINE; OKT 3; PREDNISOLONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CADAVER KIDNEY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; GENITAL BLEEDING; GRAFT SURVIVAL; HEART BEAT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIC HEART DISEASE; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; KIDNEY TUBULE NECROSIS; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PANCREATITIS; PARALYTIC ILEUS; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; CADAVER; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISCHEMIA; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; KIDNEY TUBULAR NECROSIS, ACUTE; LONGITUDINAL STUDIES; MALE; METHYLPREDNISOLONE; SURVIVAL RATE; TACROLIMUS; TISSUE AND ORGAN HARVESTING; TISSUE DONORS; TREATMENT OUTCOME;

EID: 15844431340     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2005.00200.x     Document Type: Article

References (14)

1. Starzl TE, Todo S, Fung J et al. FK506 for liver kidney, and pancreas transplantation. Lancet 1989: 2: 1000.
2. Ohshima S, Fujita T, Asano H et al. The effect of cyclosporine on the early postoperative function of allograft kidneys with warm ischemic damage. Transplant Proc 1987: 19: 2081.
3. Fujita T, Matsui M, Yamaoka M et al. Clinical application of in situ renal cooling: experience with 61 cardiac-arrest donors. Transplant Proc 1989: 21: 1657.
4. Ohshima S, Ono Y, Hattori R et al. Long-term outcome of cadaver kidney transplants from non-heart-beating Donors. Transplant Proc 2001: 33: 3764.
5. Ohshima S, Fujita T, Ono Y et al. Immunosuppressive treatment of primary cadaveric renal transplant patients receiving kidneys from non-heart beating donors. Artif Organs 1996: 20: 1130.
6. Cecka JM, Terasaki PI. The UNOS scientific renul transplant registry. In: Terasaki PI, ed. Clinical Transplants. Los Angeles: UCLA Tissue Typing Laboratory, 1998; 1.
7. Vincenti F. Tacrolimus (FK506) in kidney transplantation: five-year survival results of the U.S. muticenter, randomized, comparative trial. Transplant Proc 2001: 33: 1019.
8. Shapiro R, Jordan M, Scantlebury VP et al. Renal transplantation at the university of Pittsburgh: the impact of FK506. In: Terasaki PI, ed. Clinical Transplants. Los Angeles: UCLA Tissue Typing Laboratory, 1994; 237.
9. Pirsch JD, Miller J, Deierhoi MH et al. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 1997: 63: 977.
10. Johnson C, Ahsan N, Gonwa T et al. Randomized trial of tacrolimimus (Prograf) in combination with azathioprine or mychophenolate mofetil versus cyclosporine (Neonal) with mycophenolate mofetil after cadaveric kidney transplantation. Transplantation 2000: 69: 834.
11. Mayer AD, Dmitrewski J, Squifflet JP et al. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection. Transplantation 1997: 64: 436.
12. Kinukawa T, Ohshima S, Ono Y et al. Long-term comparison of taclorimus and cyclosporine-based immunosuppression in kidney recipients with graft from non-heart-beating cadaver donor. Transplant Proc 1998: 30: 1227.
13. Hattori R, Ono Y, Ohshima S et al. Long-term outcome of kidney transplants from non-heart-beating donors: multivariate analysis of factors affecting graft survival. Transplant Proc 1999: 31: 2847.
14. Tajra LC, Martin X, Margonari J et al. In vivo effects of monoclonal antibodies against rat beta(2) integrins on kidney ischemia-reperfusion injury. J Surg Res 1999: 87: 32.